14th May 2025 10:52
Spire Healthcare Group PLC - London-based healthcare company - Says it is "pleased to confirm that performance in the period has been in line with our expectations and the 2025 guidance provided". Adds that its "on-going transformation programme" remains on track with the benefits seen as weighted towards the second half of 2025. Says it expects the programme to deliver "at least" GBP30 million in "efficiencies" this year. Furthermore, Spire confirms that due to having 100% direct UK revenue exposure, it does not currently expect recent tariff announcements to cause any material cost or supply chain impacts. Finally, Spire says it was recently named a founding supplier as part of the UK government's National Strategic Supplier Relationship programme, adding: "We look forward to working with the NHS to build a strong, long term and sustainable footing for increased NHS commissioning." Read More
